Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0KH5R
|
||||
| Former ID |
DIB020900
|
||||
| Drug Name |
SB 215505
|
||||
| Synonyms |
SB-215505; SB-215,505
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [539200] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H16ClN3O
|
||||
| InChI |
InChI=1S/C19H16ClN3O/c1-12-10-13-7-9-23(18(13)11-15(12)20)19(24)22-17-6-2-5-16-14(17)4-3-8-21-16/h2-6,8,10-11H,7,9H2,1H3,(H,22,24)
|
||||
| InChIKey |
HOVMHIRTZYQSKM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Antagonist | [525458] | |
| 5-hydroxytryptamine 2B receptor | Target Info | Antagonist | [525458] | ||
| 5-hydroxytryptamine 2C receptor | Target Info | Antagonist | [525458] | ||
| WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| SIDS Susceptibility Pathways | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.